Correlation Between Veracyte and Day One

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Veracyte and Day One at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Veracyte and Day One into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Veracyte and Day One Biopharmaceuticals, you can compare the effects of market volatilities on Veracyte and Day One and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Veracyte with a short position of Day One. Check out your portfolio center. Please also check ongoing floating volatility patterns of Veracyte and Day One.

Diversification Opportunities for Veracyte and Day One

-0.47
  Correlation Coefficient

Very good diversification

The 3 months correlation between Veracyte and Day is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Veracyte and Day One Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Day One Biopharmaceu and Veracyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Veracyte are associated (or correlated) with Day One. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Day One Biopharmaceu has no effect on the direction of Veracyte i.e., Veracyte and Day One go up and down completely randomly.

Pair Corralation between Veracyte and Day One

Given the investment horizon of 90 days Veracyte is expected to generate 1.63 times more return on investment than Day One. However, Veracyte is 1.63 times more volatile than Day One Biopharmaceuticals. It trades about 0.1 of its potential returns per unit of risk. Day One Biopharmaceuticals is currently generating about -0.11 per unit of risk. If you would invest  3,894  in Veracyte on September 22, 2024 and sell it today you would earn a total of  195.00  from holding Veracyte or generate 5.01% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Veracyte  vs.  Day One Biopharmaceuticals

 Performance 
       Timeline  
Veracyte 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Veracyte are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Veracyte unveiled solid returns over the last few months and may actually be approaching a breakup point.
Day One Biopharmaceu 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Day One Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Veracyte and Day One Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Veracyte and Day One

The main advantage of trading using opposite Veracyte and Day One positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Veracyte position performs unexpectedly, Day One can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Day One will offset losses from the drop in Day One's long position.
The idea behind Veracyte and Day One Biopharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios